eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Abstracting and indexing Subscription Contact Instructions for authors
3/2017
vol. 9
 
Share:
Share:
more
 
 
abstract:
Review article

Neoplastic fever

Anna Zasowska-Nowak, Aleksandra Ciałkowska-Rysz

Online publish date: 2018/02/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Fever is a paraneoplastic symptom, that can be used to predict the diagnosis of neoplasm as well as indicate its recurrence or progression. Prolonged fever is an unfavourable symptom for patients in advanced stage of incurable disease, which can lead to dehydration, progression of cachexia, and distress. Neoplastic fever represents a serious diagnostic dilemma. There are no specific features allowing a proper diagnosis based only on the clinical picture. The diagnosis of neoplastic fever requires prior exclusion of other causes of fever, especially infections, being the most common cause of elevated temperature in cancer patients. The naproxen test should be considered in the absence of contraindications for nonsteroidal anti-inflammatory drugs because of its high positive predictive value for the diagnosis of neoplastic fever in cancer patients. Early diagnosis of neoplastic fever can help avoid unnecessary antibiotic therapy and its complications.
keywords:

cancer fever, neoplastic fever, naproxen test

references:
Zell JA, Chang JC. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer 2005; 13: 870-877.
Liaw CC, Chen JS, Wang CH i wsp. Tumor fever in patients with nasopharyngeal carcinoma: clinical experience of 67 patients. Am J Clin Oncol 1998; 21: 422-425.
Ihde DC. Paraneoplastic syndromes. Hosp Pract (Off Ed) 1987; 22: 105-112,117-124.
Loizidou A, Aoun M, Klastersky J. Fever of unknown origin in cancer patients. Crit Rev Oncol Hematol 2016; 101: 125-130.
Pasikhova Y, Ludlow S, Baluch A. Fever in patients with cancer. Cancer Control 2017; 24: 193-197.
Morita T, Tsunoda J, Inoue S i wsp. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 1999; 18: 338-346.
Bauduer F, Capdupuy C, Renoux M. Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support Care Cancer 2000; 8: 302-306.
Fantoni M, Ricci F, Del Borgo C i wsp. Symptom profile in terminally ill AIDS patients. AIDS Patient Care STDS 1996; 10: 171-173.
Toussaint E, Bahel-Ball E, Vekemans M i wsp. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 2006; 14: 763-769.
Graczyk M, Krajnik M, Woroń J i wsp. Use of opioids as one of the causes of fever in patients with advanced cancer. Int J Immunopathol Pharmacol 2017; 30: 98-104.
Bartfai T, Conti B. Fever. Sci World J 2010; 10: 490-503.
Tansey EA, Johnson CD. Recent advances in thermoregulation. Adv Physiol Educ 2015; 39: 139-148.
Malvar Ddo C, Soares DM, Fabricio AS i wsp. The antipyretic effect of dipyrone is unrelated to inhibition of PGE(2) synthesis in the hypothalamus. Br J Pharmacol 2011; 162: 1401-1409.
Shomali W, Hachem R, Chaftari AM i wsp. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer 2012; 118: 5823-5829.
Kallio R, Bloigu A, Surcel HM i wsp. C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 2001; 9: 124-128.
Tang BM, Eslick GD, Craig JC i wsp. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 210-217.
Penel N, Fournier C, Clisant S i wsp. Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer 2004; 12: 593-598.
Patel RA, Gallagher JC. Drug fever. Pharmacotherapy 2010; 30: 57-69.
Chang JC. How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test. Heart Lung 1987; 16: 122-127.
Chang JC. Antipyretic effect of naproxen and corticosteroids on neoplastic fever. J Pain Symptom Manage 1988; 3: 141-144.
Chang JC, Gross HM. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med 1984; 76: 597-603.
Alsirafy SA, El Mesidy SM, Abou-Elela EN, Elfaramawy YI. Naproxen test for neoplastic fever may reduce suffering. J Palliat Med 2011; 14: 665-667.
Oborilová A, Mayer J, Pospísil Z i wsp. Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol. J Pain Symptom Manage 2002; 24: 608-615.
Alves JG, Almeida ND, Almeida CD. Tepid sponging plus dipyrone versus dipyrone alone for reducing body temperature in febrile children. Sao Paolo Med J 2008; 126: 107-111.
Gozzoli V, Treggiari MM, Kleger GR i wsp. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004; 30: 401-407.
Tsavaris N, Zinelis A, Karabelis A i wsp. A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever. J Intern Med 1990; 228: 451-455.
Tsavaris N, Zinelis A, Tsoutsos H i wsp. The response of paraneoplastic fever of lymphomas and solid tumours to the administration of naproxen. J Intern Med 1991; 230: 549-550.
Chang JC, Gross HM. Neoplastic fever responds to the treatment of an adequate dose of naproxen. J Clin Oncol 1985; 3: 552-558.
Berbotto GA, Asef SG, Elias G i wsp. Antipyretic effect of indomethacin vs aspirin in fever of tumor origin. Medicina (B Aires) 1993; 53: 35-38.
Warshaw AL, Carey RW, Robinson DR. Control of fever associated with visceral cancers by indomethacin. Surgery 1981; 89: 414-416.
Süleyman H, Demircan B, Karagöz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep 2007; 59: 247-258.
Malvar Ddo C, Aquiar FA, Vaz Ade L i wsp. Dipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2-dependent and -independent fever while 4-AA only blocks PGE2 -dependent fever. Br J Pharmacol 2014; 171: 3666-3679.
Chiumello D, Gotti M, Vergani G. Paracetamol in fever in critically ill patients-an update. J Crit Care 2017; 38: 245-252.
Foggo V, Cavenagh J. Malignant causes of fever of unknown origin. Clin Med (Lond) 2015; 15: 292-294.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe